Stay updated on Safety & Efficacy of Dupilumab in Young Children Clinical Trial
Sign up to get notified when there's something new on the Safety & Efficacy of Dupilumab in Young Children Clinical Trial page.

Latest updates to the Safety & Efficacy of Dupilumab in Young Children Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe web page has undergone significant changes, including the removal of detailed descriptions of a phase 2/3 study on dupilumab for atopic dermatitis in young children, while adding new information about the study's interventional model, masking description, and collaborators.SummaryDifference13%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.7%
- Check87 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.7%
Stay in the know with updates to Safety & Efficacy of Dupilumab in Young Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety & Efficacy of Dupilumab in Young Children Clinical Trial page.